
Andrew Ira Spitzer MD
Hip & Knee Reconstructive Surgery
Director, Cedars-Sinai Joint Replacement Program
Join to View Full Profile
444 S San Vicente BlvdSuite 603Los Angeles, CA 90048
Phone+1 310-423-9211
Fax+1 310-665-7256
Dr. Spitzer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Orthopaedic Surgery, 1992 - 1993
- University of Pennsylvania Health SystemResidency, Orthopaedic Surgery, 1987 - 1992
- David Geffen School of Medicine at UCLAClass of 1987
Certifications & Licensure
- CA State Medical License 1992 - 2026
- MA State Medical License 1992 - 2011
- PA State Medical License 1990 - 2008
- American Board of Orthopaedic Surgery Orthopaedic Surgery
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
Publications & Presentations
PubMed
- Association of Knee Osteoarthritis Treatment Types, Patient Characteristics, and Medical History With Subsequent Risk for Total Knee Arthroplasty: Data From a New Real...Andrew L Concoff, Jennifer H Lin, Andrew I Spitzer, Vinod Dasa, Adam Rivadeneyra
Arthroplasty Today. 2025-04-01 - Improved Sleep Associated With Triamcinolone Acetonide Extended-Release Injections for Knee Osteoarthritis: Use of a New Real-World Registry.Michael A Mont, Jennifer H Lin, Andrew I Spitzer, Vinod Dasa, Adam Rivadeneyra
Arthroplasty Today. 2025-04-01 - Treatment Journey for Nonoperative Symptomatic Knee Osteoarthritis: Data from a New Real-World Registry.Andrew I Spitzer, Michael A Mont, Jennifer H Lin, Vinod Dasa, Adam Rivadeneyra
Surgical Technology International. 2025-03-21
Press Mentions
- Flexion Therapeutics Announces Upcoming Presentations at the 2019 Osteoarthritis Research Society International (OARSI) World CongressMay 2nd, 2019
- Flexion Therapeutics Announces Publication of Data from Repeat Administration Trial of ZILRETTA® (Triamcinolone Acetonide Extended-Release Injectable Suspension) in Rheumatology and TherapyFebruary 11th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: